# Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

Study · id `cardio:ct-nct02944123` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02944123](<https://clinicaltrials.gov/study/NCT02944123>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02944123

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT02944123. Randomized; single masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2020-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02944123, source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)
- Started: 2016-09 (actual) (ClinicalTrials.gov record NCT02944123, source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)
- Primary completion: 2020-02 (actual) (ClinicalTrials.gov record NCT02944123, source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)
- Completion: 2020-06 (actual) (ClinicalTrials.gov record NCT02944123, source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02944123, source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02944123-2020-08-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Clopidogrel 75 mg
- Intervention (Drug): Prasugrel 5 mg
- Intervention (Drug): Ticagrelor 45 mg
- Lead sponsor: Dong-A University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Dong-A University (`cardio:org-dong-a-university`)

## Provenance

Content hash: a1ec019b9954eee9796102e28e03ceb85f58a98868549500b2a3811b394de9ff
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
